Advertisement
Surmodics, Inc. (SRDX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 38.13 |
| Open | 38.22 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 37.51 - 38.37 |
| 52 Week Range | 25.17 - 42.44 |
| Volume | |
| Avg. Volume | 312,046 |
| Market Cap | 546.141M |
| Beta (5Y Monthly) | 1.20 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
SRDX Stock Down Despite FDA Clearance for Pounce XL System
Surmodics' latest regulatory achievement is likely to broaden the platform's clinical utility and significantly expand its addressable market.
- Zacks
SurModics (SRDX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
SurModics (SRDX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.